SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-14-047741
Filing Date
2014-08-07
Accepted
2014-08-07 16:30:37
Documents
11
Period of Report
2014-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q v384196_10q.htm 10-Q 277493
2 EXHIBIT 31.1 v384196_ex31-1.htm EX-31.1 9762
3 EXHIBIT 31.2 v384196_ex31-2.htm EX-31.2 9749
4 EXHIBIT 32.1 v384196_ex32-1.htm EX-32.1 4176
5 EXHIBIT 32.2 v384196_ex32-2.htm EX-32.2 4307
  Complete submission text file 0001144204-14-047741.txt   1842086

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT plx-20140630.xml EX-101.INS 133907
7 XBRL TAXONOMY EXTENSION SCHEMA plx-20140630.xsd EX-101.SCH 18247
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE plx-20140630_cal.xml EX-101.CAL 35449
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE plx-20140630_def.xml EX-101.DEF 52800
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE plx-20140630_lab.xml EX-101.LAB 305102
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE plx-20140630_pre.xml EX-101.PRE 130002
Mailing Address 2 SNUNIT ST SCIENCE PARK, POB 455 CARMIEL L3 20100
Business Address 2 SNUNIT ST SCIENCE PARK, POB 455 CARMIEL L3 20100 972-4-988-9488
Protalix BioTherapeutics, Inc. (Filer) CIK: 0001006281 (see all company filings)

IRS No.: 650643773 | State of Incorp.: FL | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33357 | Film No.: 141024314
SIC: 2836 Biological Products, (No Diagnostic Substances)